Clinical Trials Browser

Phase 2 × Leukemia, Hairy Cell × Specimen Handling × Clear all

NCT01841723 2026-05-13

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT06311227 2026-05-13

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell